Clinical Trial Update: Blood Test to Measure DNA Damage in Blood

View source ↗

Summary

A clinical trial evaluating a blood test to measure DNA damage in blood for prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Prostate Cancer | Status: TERMINATED